These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1168 related items for PubMed ID: 7852109

  • 41. Importance of effective central nervous system therapy in isolated bone marrow relapse of childhood acute lymphoblastic leukemia. BFM (Berlin-Frankfurt-Münster) Relapse Study Group.
    Bührer C, Hartmann R, Fengler R, Schober S, Arlt I, Loewke M, Henze G.
    Blood; 1994 Jun 15; 83(12):3468-72. PubMed ID: 8204875
    [Abstract] [Full Text] [Related]

  • 42. Treating childhood acute lymphoblastic leukemia without cranial irradiation.
    Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Raimondi SC, Onciu M, Coustan-Smith E, Kun LE, Jeha S, Cheng C, Howard SC, Simmons V, Bayles A, Metzger ML, Boyett JM, Leung W, Handgretinger R, Downing JR, Evans WE, Relling MV.
    N Engl J Med; 2009 Jun 25; 360(26):2730-41. PubMed ID: 19553647
    [Abstract] [Full Text] [Related]

  • 43. Comparison of maintenance treatment regimens for first central nervous system relapse in children with acute lymphocytic leukemia. A Pediatric Oncology Group study.
    Land VJ, Thomas PR, Boyett JM, Glicksman AS, Culbert S, Castleberry RP, Berry DH, Vats T, Humphrey GB.
    Cancer; 1985 Jul 01; 56(1):81-7. PubMed ID: 3859359
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber ALL Consortium Protocol 87-01.
    LeClerc JM, Billett AL, Gelber RD, Dalton V, Tarbell N, Lipton JM, Barr R, Clavell LA, Asselin B, Hurwitz C, Schorin M, Lipshultz SE, Declerck L, Silverman LB, Cohen HJ, Sallan SE.
    J Clin Oncol; 2002 Jan 01; 20(1):237-46. PubMed ID: 11773175
    [Abstract] [Full Text] [Related]

  • 48. High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group.
    Veerman AJ, Hählen K, Kamps WA, Van Leeuwen EF, De Vaan GA, Solbu G, Suciu S, Van Wering ER, Van der Does-Van der Berg A.
    J Clin Oncol; 1996 Mar 01; 14(3):911-8. PubMed ID: 8622039
    [Abstract] [Full Text] [Related]

  • 49. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital.
    Pui CH, Sandlund JT, Pei D, Campana D, Rivera GK, Ribeiro RC, Rubnitz JE, Razzouk BI, Howard SC, Hudson MM, Cheng C, Kun LE, Raimondi SC, Behm FG, Downing JR, Relling MV, Evans WE, Total Therapy Study XIIIB at St Jude Children's Research Hospital.
    Blood; 2004 Nov 01; 104(9):2690-6. PubMed ID: 15251979
    [Abstract] [Full Text] [Related]

  • 50. Risk-directed therapy for childhood acute lymphoblastic leukemia. Results of the Associazione Italiana Ematologia Oncologia Pediatrica '82 studies.
    Vecchi V, Aricò M, Basso G, Ceci A, Madon E, Mandelli F, Masera G, Massimo L, Pession A, Zanesco L.
    Cancer; 1993 Oct 15; 72(8):2517-24. PubMed ID: 8402470
    [Abstract] [Full Text] [Related]

  • 51. Current management and challenges of malignant disease in the CNS in paediatric leukaemia.
    Pui CH, Howard SC.
    Lancet Oncol; 2008 Mar 15; 9(3):257-68. PubMed ID: 18308251
    [Abstract] [Full Text] [Related]

  • 52. Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology Association.
    Uderzo C, Valsecchi MG, Bacigalupo A, Meloni G, Messina C, Polchi P, Di Girolamo G, Dini G, Miniero R, Locatelli F.
    J Clin Oncol; 1995 Feb 15; 13(2):352-8. PubMed ID: 7844596
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome. Berlin-Frankfurt-Münster Relapse Study Group.
    Bührer C, Hartmann R, Fengler R, Rath B, Schrappe M, Janka-Schaub G, Henze G.
    J Clin Oncol; 1996 Oct 15; 14(10):2812-7. PubMed ID: 8874343
    [Abstract] [Full Text] [Related]

  • 58. CNS late-effects after ALL therapy in childhood. Part III: neuropsychological performance in long-term survivors of childhood ALL: impairments of concentration, attention, and memory.
    Langer T, Martus P, Ottensmeier H, Hertzberg H, Beck JD, Meier W.
    Med Pediatr Oncol; 2002 May 15; 38(5):320-8. PubMed ID: 11979456
    [Abstract] [Full Text] [Related]

  • 59. Evolving of therapeutic strategies for CNS-PNET.
    Massimino M, Gandola L, Biassoni V, Spreafico F, Schiavello E, Poggi G, Pecori E, Vajna De Pava M, Modena P, Antonelli M, Giangaspero F.
    Pediatr Blood Cancer; 2013 Dec 15; 60(12):2031-5. PubMed ID: 23852767
    [Abstract] [Full Text] [Related]

  • 60. [Significance of recurrence in children with acute lymphatic leukemia].
    Behrendt H, van Leeuwen EF, Schuwirth C, Verkes RJ, Hermans J, van der Does-van den Berg A, van Wering ER.
    Tijdschr Kindergeneeskd; 1988 Apr 15; 56(2):67-72. PubMed ID: 3163855
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 59.